ATE128986T1 - Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen. - Google Patents

Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen.

Info

Publication number
ATE128986T1
ATE128986T1 AT89901007T AT89901007T ATE128986T1 AT E128986 T1 ATE128986 T1 AT E128986T1 AT 89901007 T AT89901007 T AT 89901007T AT 89901007 T AT89901007 T AT 89901007T AT E128986 T1 ATE128986 T1 AT E128986T1
Authority
AT
Austria
Prior art keywords
antigen
colon adenocarcinoma
antigens
recognize
diagnosing
Prior art date
Application number
AT89901007T
Other languages
English (en)
Inventor
Jack R Wands
Hiroshi Takahashi
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE128986T1 publication Critical patent/ATE128986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89901007T 1987-12-09 1988-12-09 Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen. ATE128986T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13077787A 1987-12-09 1987-12-09
US06/203,198 US5212085A (en) 1987-12-09 1988-06-07 Sf-25 colon adenocarcinoma antigen, and antibodies with recognize this antigen

Publications (1)

Publication Number Publication Date
ATE128986T1 true ATE128986T1 (de) 1995-10-15

Family

ID=26828802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89901007T ATE128986T1 (de) 1987-12-09 1988-12-09 Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen.

Country Status (9)

Country Link
US (1) US5212085A (de)
EP (1) EP0397700B1 (de)
JP (1) JPH03504491A (de)
AT (1) ATE128986T1 (de)
AU (1) AU629808B2 (de)
CA (1) CA1339853C (de)
DE (1) DE3854581T2 (de)
NZ (1) NZ227280A (de)
WO (1) WO1989005307A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE133994T1 (de) * 1987-12-09 1996-02-15 Gen Hospital Corp An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US6252052B1 (en) 1996-10-03 2001-06-26 Cornell Research Foundation, Inc Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies
US6723832B1 (en) 1996-10-03 2004-04-20 Ludwig Institute For Cancer Research Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
EP0526888A3 (en) * 1991-08-06 1993-09-01 Toray Industries, Inc. Monoclonal antibody reactive with human pancreas cancer tissue
AU2319392A (en) * 1992-07-07 1994-01-31 University Research Corporation Cancer immunotherapy with antibodies to cancer procoagulant
JP2573869Y2 (ja) * 1992-10-13 1998-06-04 自動車電機工業株式会社 ウオッシャノズル付ワイパアーム
US5602042A (en) * 1994-04-14 1997-02-11 Cytyc Corporation Method and apparatus for magnetically separating biological particles from a mixture
US20040254101A1 (en) * 1995-06-06 2004-12-16 Human Genome Sciences, Inc. Colon specific gene and protein and cancer
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
US6069233A (en) * 1996-10-03 2000-05-30 Memorial Sloan-Kettering Cancer Center Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
EP1320551A4 (de) * 2000-09-01 2006-12-20 Internat Bioimmune Systems Inc Identifikation und entwicklung von spezifischen monoklonalen antikörpern gegen plattenepithelkarzinom
EP2295064B1 (de) 2001-03-15 2017-02-22 Precision Biologics, Inc. Behandlung von bauchspeicheldrüsenkrebs mit einem monoklonalen antikörper
JP2010524508A (ja) * 2007-04-27 2010-07-22 ダウ グローバル テクノロジーズ インコーポレイティド 可溶性組換え二十面体ウイルス様粒子の生産及びインビボ組織化の改善
US9316645B2 (en) 2011-10-07 2016-04-19 Brown University Methods, compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging
GB201900724D0 (en) 2019-01-18 2019-03-06 King S College London Antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4661586A (en) * 1981-11-17 1987-04-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies
US4485093A (en) * 1982-08-13 1984-11-27 Runge Richard G Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
US4683200A (en) * 1984-05-17 1987-07-28 Setsuo Hirohashi Monoclonal antibody to human cancer antigen and method for producing same
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants

Also Published As

Publication number Publication date
AU2829889A (en) 1989-07-05
JPH03504491A (ja) 1991-10-03
DE3854581D1 (de) 1995-11-16
CA1339853C (en) 1998-05-05
EP0397700B1 (de) 1995-10-11
NZ227280A (en) 1992-06-25
US5212085A (en) 1993-05-18
AU629808B2 (en) 1992-10-15
EP0397700A1 (de) 1990-11-22
DE3854581T2 (de) 1996-06-13
WO1989005307A1 (en) 1989-06-15
EP0397700A4 (en) 1991-01-16

Similar Documents

Publication Publication Date Title
ATE128986T1 (de) Antigen sf-25 des darm-adenokarzinoms sowie antikörper, die dieses antigen erkennen.
ES520692A0 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
DE69434286D1 (de) Immunologische bestimmungen von prostata-spezifischem antigen
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
MX9701859A (es) Anticuerpos monoclonales en contra de antigenos asociados con carcinoma de colon humano, y usos de los mismos.
PL344190A1 (en) Novel method for the production of anti-human antigen receptors and uses thereof
ATE123652T1 (de) Antigene.
ATE133994T1 (de) An karzinoma assoziierte antigene und antikörper, die diese antigene erkennen
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
ATE137674T1 (de) Von mca 16-88 erkanntes antigen
FI924576A0 (fi) Ctaa 28a32, antigen identiefierad av mca 28a32
FR2720277B1 (fr) Méthode de traitement des cancers par régulation de la protéine P53.
SE9500148D0 (sv) Antibodies for use in cancer therapy and diagnosis
WO1999043815A3 (en) Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
BR9815775A (pt) Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
KR950016780A (ko) 신규 모노클로날 항체